logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.15.820.729.319.811.86.95.730.539117
Cocaine0.14.320.925.618.213.210.77.031.57032
Stimulants0.519.929.821.214.64.23.76.027.011245
Hypnotics and sedatives0.24.48.59.510.98.113.544.842.94955
Hallucinogens0.011.826.535.317.68.80.00.026.8340
Volatile substances5.952.014.414.98.92.50.01.521.72020
Cannabis 1.424.827.518.412.66.24.05.026.518157
Other substances 0.97.916.114.510.39.78.232.438.03300
Total0.612.622.323.616.39.26.48.830.0861426

Notes:

 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.   

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011